MV-NIS has shown impressive oncolytic activity in multiple preclinical tumor models[14,28,30-32], and its ability to promote iodide uptake in infected tumor cells has made targeted radiotherapy feasible for cancers of various origins. Here, SLC5A5 is linked to neoplasm.